Cargando…
A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine
BACKGROUND: Anticipating and controlling drug-drug interactions (DDIs) in older patients with painful diabetic peripheral neuropaty (pDPN) presents a significant challenge to providers. The purpose of this study was to examine the impact of newly initiated pregabalin or duloxetine treatment on Medic...
Autores principales: | Ellis, Jeffrey J, Sadosky, Alesia B, Ten Eyck, Laura L, Mudumby, Pallavi, Cappelleri, Joseph C, Ndehi, Lilian, Suehs, Brandon T, Parsons, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422427/ https://www.ncbi.nlm.nih.gov/pubmed/25889173 http://dx.doi.org/10.1186/s12913-015-0829-9 |
Ejemplares similares
-
Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia
por: Ellis, Jeffrey J, et al.
Publicado: (2014) -
Comparison of the Efficacy of Duloxetine and Pregabalin in Pain Relief Associated with Diabetic Neuropathy
por: Shahid, Wajeeha, et al.
Publicado: (2019) -
Impact of a Novel Cost-Saving Pharmacy Program on Pregabalin Use and Health Care Costs
por: Martin, Carolyn, et al.
Publicado: (2016) -
Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy
por: Devi, Padmini, et al.
Publicado: (2012) -
A systematic review of the effectiveness of policies restricting access to pregabalin
por: Stacey, Brett R., et al.
Publicado: (2017)